Answers are grounded in this paper and cite their sources.
Narrative review highlights SGLT2 inhibitors improve ejection fraction and reduce cardiovascular mortality in heart failure patients.
Heart failure (HF) is a multifactorial clinical condition that compromises the heart's ability to meet the body's demands. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, initially developed for the treatment of type 2 diabetes, have demonstrated significant beneficial effects in the management of HF, regardless of the presence of diabetes. To investigate the effects of long-term use of SGLT2 inhibitors in the management of heart failure, with an emphasis on associated clinical outcomes, this narrative review was conducted based on a systematic literature search, including studies published between 2019 and 2024 on the long-term effects of SGLT2 inhibitors in patients with HF. Robust clinical evidence has demonstrated that these agents significantly reduce hospitalizations and cardiovascular mortality. Studies such as DAPA-HF, EMPEROR-Reduced, and DELIVER have confirmed efficacy in different ejection fraction profiles. Furthermore, SGLT2 inhibitors promote improved cardiac function, increased ejection fraction, reduced NT-proBNP, and favorable ventricular remodeling. There were also improvements in quality of life, functional capacity, and distance covered on the 6-minute walk test. From a renal perspective, SGLT2 inhibitors slow the progression of chronic kidney disease and offer protection against acute kidney injury. The observed benefits are explained by multiple mechanisms: diuretic effects, reduction of hemodynamic overload, modulation of cardiac metabolism, and anti-inflammatory properties. Clinical response occurs rapidly, observed within a few weeks of use, even in the elderly. The use of SGLT2 inhibitors has shown a positive impact on cardiovascular and renal outcomes, as well as on quality of life.
No takes yet. Share an insight, caveat, or question.
Vieira et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: